Novo Nordisk Shifts GLP-1 Strategy as Merck Faces Cancer Drug Setback

By Ed Silverman · STAT News · 2026-09-28

STAT News reports that leading pharmaceutical manufacturers are pivoting toward direct-to-consumer sales for weight-loss injections as insurance reimbursement hits a plateau. Meanwhile, a major oncology partnership between Merck and Daiichi Sankyo has encountered regulatory frict

STAT News reports that leading pharmaceutical manufacturers are pivoting toward direct-to-consumer sales for weight-loss injections as insurance reimbursement hits a plateau. Meanwhile, a major oncology partnership between Merck and Daiichi Sankyo has encountered regulatory frict